Product How it works Pricing Blog FAQ About Contact
MacroGenics

MacroGenics (NASDAQ: MGNX) revenue

MacroGenics reported revenue of $149.5m for fiscal 2025, 0.3% less than in fiscal 2024 ($150.0m). Since fiscal 2016 its revenue has grown by 62.7%, an average growth of 5.6% a year.

MacroGenics's best year of the last 10 was fiscal 2017. The biggest drop was in fiscal 2018, −61.9%.

Revenue, in millions of US dollars91.92016157.7201760.1201864.22019104.9202077.42021151.9202258.72023150.02024149.52025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$149.5m−0.3%−$72.8m−48.7%
2024$150.0m+155.3%−$110.6m−73.7%
2023$58.7m−61.3%−$168.2m−286.4%
2022$151.9m+96.2%−$121.4m−79.9%
2021$77.4m−26.2%−$202.8m−261.9%
2020$104.9m+63.4%−$131.1m−125.0%
2019$64.2m+6.8%−$177.2m−276.0%
2018$60.1m−61.9%−$171.2m−284.8%
2017$157.7m+71.7%−$22.1m−14.0%
2016$91.9m—−$60.0m−65.3%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

MacroGenics revenue compared with its sector

By revenue for its latest fiscal year, MacroGenics ranks 263rd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; MacroGenics, −0.3%.

RankCompanyRevenueRevenue growth
261stHeron Therapeutics$154.9m7.4%
262ndAirSculpt Technologies$151.8m−15.8%
263rdMacroGenics$149.5m−0.3%
264thGrail$147.2m17.2%
265thKaryopharm Therapeutics$146.1m0.6%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of MacroGenics

How much revenue did MacroGenics make in fiscal 2025?
MacroGenics reported revenue of $149.5m for fiscal 2025, compared with $150.0m in fiscal 2024.
How much has the revenue of MacroGenics grown?
Between fiscal 2016 and fiscal 2025 it went from $91.9m to $149.5m: 62.7% more, an average growth of 5.6% a year.
What was the best year for revenue at MacroGenics?
Of its last 10 fiscal years, fiscal 2017, with $157.7m.
Where does MacroGenics rank in its sector by revenue?
It ranks 263rd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for MacroGenics come from?
From the annual report (Form 10-K) that MacroGenics files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that MacroGenics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on MacroGenics: the MacroGenics page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.